Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant M2e Influenza-A Vaccine

recombinant M2e influenza A vaccine · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant M2e Influenza-A Vaccine, covering 2012-01-16 to 2012-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults [Phase 1]

See pricing